Subsequently, Hernandez-Alvarez and colleagues reported that PGC1-α pathways were altered in T2D following 12 weeks of MICT, potentially explaining the blunted VO2peak response (Hernández-Alvarez et al., 2010). Here, PPARGC1A is linked to type 2 diabetes mellitus.